This medication is an antithrombotic agent, prescribed for anticoagulant therapy in prophylaxis and treatment of venous thrombosis, prevention of post-operative deep venous thrombosis and ...

Factor XI and XIa inhibitors in development may reduce the odds of bleeding compared with current antithrombotic therapies. Despite advances in anticoagulant therapies, bleeding remains a critical ...

For instance, an anticoagulant given to increase clotting ... The Table provides a summary of the various antithrombotic drug classes, representative agents, mechanisms of action, and approved ...

Other anticoagulant agents in development include ... The American Society of Health-System Pharmacists Antithrombotic Pharmacotherapy Traineeship was launched in 1985 and involves an intense ...

Current antithrombotic recommendations call for both aspirin ... Discharge medications included single antiplatelet therapy (SAPT) in 5.3%, DAPT in 81.7%, and an oral anticoagulant in 13%. Assignment ...